N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea

C114H113N33O5S — CID 158055731

IUPACN-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea
SMILESCN(C)CCCOc1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1.O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3nc(-c4ccc(OCCCN5CCC(O)CC5)cc4)[nH]c23)cc1.O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3nc(-c4ccccc4)[nH]c23)s1.c1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1
InChIInChI=1S/C34H38N8O3.C31H33N9O.C26H22N8.C23H20N8OS/c43-28-16-20-42(21-17-28)19-4-22-45-29-13-9-25(10-14-29)31-40-30-32(36-23-37-33(30)41-31)35-18-15-24-7-11-27(12-8-24)39-34(44)38-26-5-2-1-3-6-26;1-40(2)18-5-19-41-24-14-10-22(11-15-24)28-38-27-29(33-20-34-30(27)39-28)32-17-16-21-8-12-23(13-9-21)35-31-36-25-6-3-4-7-26(25)37-31;1-2-6-18(7-3-1)23-33-22-24(28-16-29-25(22)34-23)27-15-14-17-10-12-19(13-11-17)30-26-31-20-8-4-5-9-21(20)32-26;32-22(28-16-9-5-2-6-10-16)31-23-25-13-17(33-23)11-12-24-20-18-21(27-14-26-20)30-19(29-18)15-7-3-1-4-8-15/h1-3,5-14,23,28,43H,4,15-22H2,(H2,38,39,44)(H2,35,36,37,40,41);3-4,6-15,20H,5,16-19H2,1-2H3,(H2,35,36,37)(H2,32,33,34,38,39);1-13,16H,14-15H2,(H2,30,31,32)(H2,27,28,29,33,34);1-10,13-14H,11-12H2,(H2,25,28,31,32)(H2,24,26,27,29,30)
InChIKeyFKAKBEUHSQQVEO-UHFFFAOYSA-N
MW2057.45 g/mol
LogP21.24
Rot. Bonds38

About N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea

N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea (PubChem CID 158055731) has the molecular formula C114H113N33O5S and a molecular weight of 2057.45 g/mol. Its IUPAC name is N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea.

Molecular Properties

Compound NameN-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea
PubChem CID158055731
Molecular FormulaC114H113N33O5S
Molecular Weight2057.45 g/mol
Exact Mass2055.93
IUPAC NameN-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea
SMILESCN(C)CCCOc1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1.O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3nc(-c4ccc(OCCCN5CCC(O)CC5)cc4)[nH]c23)cc1.O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3nc(-c4ccccc4)[nH]c23)s1.c1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1
InChIInChI=1S/C34H38N8O3.C31H33N9O.C26H22N8.C23H20N8OS/c43-28-16-20-42(21-17-28)19-4-22-45-29-13-9-25(10-14-29)31-40-30-32(36-23-37-33(30)41-31)35-18-15-24-7-11-27(12-8-24)39-34(44)38-26-5-2-1-3-6-26;1-40(2)18-5-19-41-24-14-10-22(11-15-24)28-38-27-29(33-20-34-30(27)39-28)32-17-16-21-8-12-23(13-9-21)35-31-36-25-6-3-4-7-26(25)37-31;1-2-6-18(7-3-1)23-33-22-24(28-16-29-25(22)34-23)27-15-14-17-10-12-19(13-11-17)30-26-31-20-8-4-5-9-21(20)32-26;32-22(28-16-9-5-2-6-10-16)31-23-25-13-17(33-23)11-12-24-20-18-21(27-14-26-20)30-19(29-18)15-7-3-1-4-8-15/h1-3,5-14,23,28,43H,4,15-22H2,(H2,38,39,44)(H2,35,36,37,40,41);3-4,6-15,20H,5,16-19H2,1-2H3,(H2,35,36,37)(H2,32,33,34,38,39);1-13,16H,14-15H2,(H2,30,31,32)(H2,27,28,29,33,34);1-10,13-14H,11-12H2,(H2,25,28,31,32)(H2,24,26,27,29,30)
InChIKeyFKAKBEUHSQQVEO-UHFFFAOYSA-N
XLogP21.24
TPSA487.70 Ų
H-Bond Donors17
H-Bond Acceptors29
Rotatable Bonds38
Heavy Atoms153
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002057.45
LogP ≤ 521.24
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea?
The IUPAC name of N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea (CID 158055731) is N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea.
What is the SMILES notation for N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea?
The canonical SMILES for N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea is CN(C)CCCOc1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1.O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3nc(-c4ccc(OCCCN5CCC(O)CC5)cc4)[nH]c23)cc1.O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3nc(-c4ccccc4)[nH]c23)s1.c1ccc(-c2nc3ncnc(NCCc4ccc(Nc5nc6ccccc6[nH]5)cc4)c3[nH]2)cc1.
What is the InChIKey of N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea?
The InChIKey is FKAKBEUHSQQVEO-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H38N8O3.C31H33N9O.C26H22N8.C23H20N8OS/c43-28-16-20-42(21-17-28)19-4-22-45-29-13-9-25(10-14-29)31-40-30-32(36-23-37-33(30)41-31)35-18-15-24-7-11-27(12-8-24)39-34(44)38-26-5-2-1-3-6-26;1-40(2)18-5-19-41-24-14-10-22(11-15-24)28-38-27-29(33-20-34-30(27)39-28)32-17-16-21-8-12-23(13-9-21)35-31-36-25-6-3-4-7-26(25)37-31;1-2-6-18(7-3-1)23-33-22-24(28-16-29-25(22)34-23)27-15-14-17-10-12-19(13-11-17)30-26-31-20-8-4-5-9-21(20)32-26;32-22(28-16-9-5-2-6-10-16)31-23-25-13-17(33-23)11-12-24-20-18-21(27-14-26-20)30-19(29-18)15-7-3-1-4-8-15/h1-3,5-14,23,28,43H,4,15-22H2,(H2,38,39,44)(H2,35,36,37,40,41);3-4,6-15,20H,5,16-19H2,1-2H3,(H2,35,36,37)(H2,32,33,34,38,39);1-13,16H,14-15H2,(H2,30,31,32)(H2,27,28,29,33,34);1-10,13-14H,11-12H2,(H2,25,28,31,32)(H2,24,26,27,29,30).
What are the key properties of N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea?
N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea has a molecular weight of 2057.45 g/mol, XLogP of 21.24, 38 rotatable bonds, 17 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-[4-[3-(dimethylamino)propoxy]phenyl]-7H-purin-6-amine;N-[2-[4-(1H-benzimidazol-2-ylamino)phenyl]ethyl]-8-phenyl-7H-purin-6-amine;1-[4-[2-[[8-[4-[3-(4-hydroxypiperidin-1-yl)propoxy]phenyl]-7H-purin-6-yl]amino]ethyl]phenyl]-3-phenylurea;1-phenyl-3-[5-[2-[(8-phenyl-7H-purin-6-yl)amino]ethyl]-1,3-thiazol-2-yl]urea is sourced from PubChem (CID 158055731), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).